DK536284A - Antipancreasinflammationspraeparater - Google Patents

Antipancreasinflammationspraeparater Download PDF

Info

Publication number
DK536284A
DK536284A DK536284A DK536284A DK536284A DK 536284 A DK536284 A DK 536284A DK 536284 A DK536284 A DK 536284A DK 536284 A DK536284 A DK 536284A DK 536284 A DK536284 A DK 536284A
Authority
DK
Denmark
Prior art keywords
pct
antipancreas
inflammation
preparations
inflammations
Prior art date
Application number
DK536284A
Other languages
English (en)
Other versions
DK536284D0 (da
Inventor
Laszlo Madi-Szabo
Margit Morvai
Eva Horvath
Sandor Jancso
Piroska Tamasi
Istvan Kovacs
Ilona Maria Kiss
Gyoergy Bacsa
Maria Kubala
Magdolna Bene
Original Assignee
Biogal Gyogyszergyar
Alkaloida Vegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar, Alkaloida Vegyeszeti Gyar filed Critical Biogal Gyogyszergyar
Publication of DK536284A publication Critical patent/DK536284A/da
Publication of DK536284D0 publication Critical patent/DK536284D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK536284A 1983-03-11 1984-11-09 Antipancreasinflammationspraeparater DK536284D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU83842A HU190072B (en) 1983-03-11 1983-03-11 Process for production of medical preparatives with sinergetic influence
PCT/HU1984/000016 WO1984003442A1 (en) 1983-03-11 1984-03-12 Pharmaceutical compositions of anti-pancreatic inflammatory effect

Publications (2)

Publication Number Publication Date
DK536284A true DK536284A (da) 1984-11-09
DK536284D0 DK536284D0 (da) 1984-11-09

Family

ID=10951646

Family Applications (1)

Application Number Title Priority Date Filing Date
DK536284A DK536284D0 (da) 1983-03-11 1984-11-09 Antipancreasinflammationspraeparater

Country Status (11)

Country Link
US (1) US4705779A (da)
EP (1) EP0137832B1 (da)
JP (1) JPS60500866A (da)
AT (1) ATE28794T1 (da)
AU (1) AU563697B2 (da)
DE (1) DE3465250D1 (da)
DK (1) DK536284D0 (da)
FI (1) FI844398L (da)
HU (1) HU190072B (da)
RO (1) RO92632B (da)
WO (1) WO1984003442A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
PT1934208E (pt) 2005-10-04 2011-06-01 Bayer Schering Pharma Ag Nova forma polimorfa de 5-cloro-n-({(5s)-2-oxo-3-[4-(3- oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2- tiofenocarboxamida
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR917M (da) * 1961-02-10 1961-11-06
FR1611M (fr) * 1961-11-07 1962-12-17 Maurice Wahl Nouveau médicament, pour le traitement des congestions inflammatoires, en particulier des reins.
CH487171A (de) * 1963-10-22 1970-03-15 Siegfried Ag Verfahren zur Herstellung therapeutisch wirksamer 1,2-Dihydro-1,2,4-benztriazine
FR2128207B1 (da) * 1971-03-11 1974-08-02 Zyma Sa
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
CA1100237A (en) * 1977-03-23 1981-04-28 Roger F.W. Pease Multiple electron beam exposure system
GB1595351A (en) * 1978-03-01 1981-08-12 Inverni Della Beffa Spa Pharmaceutical compositions containing flavylium compounds
FR2437838A1 (fr) * 1978-07-25 1980-04-30 Roecar Holdings Nv Medicament pour le traitement de l'adenome benin de la prostate
ATE16150T1 (de) * 1979-11-10 1985-11-15 Siegfried Ag Xanthinoxydasehemmer und verwendung von benztriazinderivaten.
US4325949A (en) * 1980-02-15 1982-04-20 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
DE3047487A1 (de) * 1980-12-17 1982-07-08 Continental Pharma S.A., Bruxelles "pharmazeutische zubereitung zur behandlung von degenerativen erkrankungen der gelenkknorpel und verfahren zu ihrer verwendung"

Also Published As

Publication number Publication date
WO1984003442A1 (en) 1984-09-13
DE3465250D1 (en) 1987-09-17
EP0137832A1 (en) 1985-04-24
EP0137832B1 (en) 1987-08-12
AU563697B2 (en) 1987-07-16
FI844398A0 (fi) 1984-11-08
HU190072B (en) 1986-08-28
RO92632B (ro) 1987-10-31
HUT35520A (en) 1985-07-29
ATE28794T1 (de) 1987-08-15
DK536284D0 (da) 1984-11-09
JPS60500866A (ja) 1985-06-06
US4705779A (en) 1987-11-10
FI844398A7 (fi) 1984-11-08
FI844398L (fi) 1984-11-08
AU2696584A (en) 1984-09-28
RO92632A (ro) 1987-10-30

Similar Documents

Publication Publication Date Title
JO1552B1 (en) New pyridizinamine derivatives
DE3568272D1 (en) 4-vinylbenzoic-acid derivatives, their preparation and their use as therapeutical compositions and as ligands
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
DE69811062D1 (de) Polyaromatische antivirale zusammensetzungen
HUT77627A (hu) 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények
AU561016B2 (en) N-glycosylated carboxamide derivatives
SE8204237D0 (sv) Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
IT8519327A0 (it) Derivati di furo-(3,4-c)-piridina 6-sostituiti,procedimento per laloro preparazione e composizioni terapeutiche che li contengono
CA2002859A1 (en) Method of treating epithelial disorders
DK536284D0 (da) Antipancreasinflammationspraeparater
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
JPS5547657A (en) Fluorine contained 1*44dihydropyridine compound and medical use
ES8609312A1 (es) Procedimiento para la preparacion de silibinina exenta de isosilibina
ZA859382B (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
DE3361990D1 (en) Alkylene-bridged guanidino-thiazole derivatives, method for their preparation and their use as medicaments
IT8348743A0 (it) Derivati di 2,5-diammino-1,4-diazolo,procedimento per prepararli e composizioni farmaceutiche che licontengono
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
DE3161193D1 (en) 5-aminotetrazole derivatives of retinoic acids, their preparation and pharmaceutical compositions containing them
IT8320920A0 (it) Derivati di cicloalcani, procedimento per la loro preparazione e composizioni che licontengono.
IT1228437B (it) "derivati di 2,3,4,5,6,7 esaidro 2,7-metano-1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment